Long Term Effects of Heat and Moisture Exchangers (HMEs)
- Conditions
- Laryngectomy; Status
- Interventions
- Device: Provox Life
- Registration Number
- NCT06084611
- Lead Sponsor
- Atos Medical AB
- Brief Summary
Assessment of long term effect of Provox Life HME use on pulmonary symptoms in laryngectomized patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 80
- Total laryngectomy, irrespective of pharynx reconstruction method
- 18 years or older
- Longer than 3 months after total laryngectomy
- Longer than 6 weeks after postoperative radiotherapy
- Current use of HMEs (within last 3 months)
- Medical problems prohibiting the use of HME
- Active recurrent or metastatic disease (medical deterioration)
- Recent pulmonary infections/unstable pulmonary condition
- Insufficient physical, cognitive, or mental ability required to attach, remove or operate the devices themselves
- Low tidal volumes
- Unable to understand the Participant Information and/or unable to give Informed Consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Provox Life HME Provox Life Use of Provox Life HMEs and attachment
- Primary Outcome Measures
Name Time Method CASA-Q Score Baseline, 3 months, 6 months, 9 months assessed with validated Coughing and Sputum Assessment Questionnaire (CASA-Q). Score between 0 and 100, with higher scores meaning less symptoms and less impact.
- Secondary Outcome Measures
Name Time Method Quality of Life by EQ-5D-5L Baseline, 3 months, 6 months, 9 months patient reported, the descriptive system assesses health in five dimensions, from which a health state index score is calculated, range from 0 to 1, with higher scores indicating higher health utility
Jenkins sleep evaluation questionnaire Baseline, 3 months, 6 months, 9 months Patient reported to assess sleep quality. Score between 0 and 20, with higher score the more sleep disturbances
Number of involuntary coughs per 24 hours Baseline, 3 months, 6 months, 9 months Patient reported, recorded by tally sheeting
Forced Expectoration Baseline, 3 months, 6 months, 9 months Patient reported, recorded by tally sheeting
Study-specific questionnaire to assess number of complications and medical treatments Baseline, 3 months, 6 months, 9 months Study specific questionnaire to record complications and consumption of medications, diagnostics, treatment, medical care, medical transportation, sick leave
Questionnaire to assess Shortness of Breath Baseline, 3 months, 6 months, 9 months from Ackerstaff et al., 1993
Voice handicap Index Baseline, 3 months, 6 months, 9 months patient reported outcome, score from 0-40, with higher scores indicating greater voice-related handicap.
Consumption of medical devices (Number of devices used) Baseline, 3 months, 6 months, 9 months Number of devices used, by use of patient diary recoding number of devices used
Trial Locations
- Locations (1)
Instituto de Cancer Dr. Arnaldo
🇧🇷São Paulo, Brazil